CATX Operating Cash Flow Growth
Perspective Therapeutics Inc · Operating Cash Flow Growth
CATX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-43.68%period ending
CATX TTM Cash from Operations YoY % (-102.03% → -43.68%)
Year-over-year change
High-resolution chart · PNG
CATX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -43.6773% | |
| -71.9343% | |
| -350.8801% | |
| -12,031.1782% | |
| -357.0632% | |
| -302.6683% | |
| 50.4402% | |
| 97.74% | |
| 36.8702% | |
| 22.7357% | |
| -311.6538% | |
| -316.7817% | |
| -191.1673% | |
| -190.854% | |
| -74.5911% | |
| -61.2263% | |
| -171.7659% | |
| -131.2817% | |
| -82.906% | |
| -37.7931% | |
| 22.0818% | |
| 32.054% | |
| 33.9915% | |
| 18.6797% | |
| 27.8867% | |
| 31.4586% | |
| 19.0331% | |
| 27.7768% | |
| 11.6071% | |
| -0.639% | |
| 10.6766% | |
| 5.9302% | |
| 0% | |
| 4.0347% | |
| -18.1534% | |
| -45.8237% | |
| -47.0545% | |
| -72.6654% | |
| -35.1237% | |
| -18.3676% | |
| -10.2904% | |
| 14.8421% | |
| -13.4363% | |
| -0.2381% | |
| -9.0959% | |
| -28.2917% | |
| 1.0188% | |
| -15.6073% | |
| -5.6263% | |
| -4.5625% | |
| -11.3551% | |
| -5.813% | |
| -24.859% | |
| -18.8413% | |
| -37.3513% | |
| -22.5618% | |
| -1.1933% | |
| 1.5676% | |
| 18.089% | |
| 18.027% | |
| 10.6227% | |
| 16.3656% | |
| 14.929% | |
| 18.5422% | |
| 31.465% | |
| 28.7385% | |
| 41.286% | |
| 45.5713% | |
| 48.8831% | |
| 44.7817% | |
| 35.616% | |
| 15.2507% | |
| -7.2703% | |
| 5.2136% | |
| -15.4913% | |
| -4.9423% | |
| -2.8364% | |
| -47.6891% | |
| -88.4883% | |
| -292.4939% | |
| -47,146.4713% | |
| -35,288.7628% | |
| -18,457.8472% | |
| 14.3697% | |
| 26.5119% | |
| 48.1811% | |
| 0.0536% | |
| -3.9314% | |
| 3.7082% | |
| -114.5742% | |
| -49.9541% | |
| 29.3672% | |
| -5.4117% | |
| 39.829% | |
| 58.9558% | |
| -73.8938% | |
| -50.0423% | |
| -98.6918% | |
| -108.116% | |
| -103.9867% |